Solugen valuation, funding and investors
Solugen works in sustainable chemical manufacturing, based in Houston, United States. Founded in 2016, it has about 136 employees.
- Last round
- Growth · $50.0M · Mar 2026
- Valuation at last round
- $556M · implied
- Headcount
- 136 · flat
- Grade
- B
- Founded
- 2016
Solugen valuation today
VCMC values Solugen at $584M today, with a range of $369M to $917M and a grade of B. The valuation starts from its last funding round, a growth round in Mar 2026.
Valuation by date (136 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2016 | $5.86M | $2.13M – $16.1M | $7.03M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $5.88M | $2.14M – $16.2M | $7.22M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $5.91M | $2.15M – $16.2M | $7.40M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $5.93M | $2.16M – $16.3M | $7.60M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $5.95M | $2.17M – $16.4M | $7.80M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $5.98M | $2.18M – $16.4M | $8.01M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $6.00M | $2.18M – $16.5M | $8.22M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $6.16M | $2.24M – $16.9M | $8.44M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $6.33M | $2.30M – $17.4M | $8.67M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $6.49M | $2.36M – $17.8M | $8.90M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $6.67M | $2.43M – $18.3M | $9.14M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $6.84M | $2.49M – $18.8M | $9.38M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $7.03M | $2.56M – $19.3M | $9.63M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $7.22M | $2.63M – $19.8M | $9.89M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $7.39M | $2.69M – $20.3M | $10.1M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $7.59M | $2.76M – $20.9M | $10.4M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $7.79M | $2.84M – $21.4M | $10.7M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $8.00M | $2.91M – $22.0M | $11.0M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $8.21M | $2.99M – $22.6M | $11.3M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $8.44M | $3.07M – $23.2M | $11.6M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $8.67M | $3.15M – $23.8M | $11.9M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $8.89M | $3.24M – $24.4M | $12.2M (+37%) | before first round | – | unknown | D | 0% |
| 25 Oct 2017 | $17.6M | $11.6M – $53.6M | $35.2M (+100%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $17.9M | $11.6M – $53.6M | $35.2M (+97%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $18.9M | $11.6M – $53.6M | $35.2M (+86%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $20.1M | $11.6M – $53.6M | $35.2M (+75%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $21.3M | $11.6M – $53.6M | $35.2M (+65%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $22.4M | $11.6M – $53.6M | $35.2M (+57%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $23.8M | $11.6M – $53.6M | $35.2M (+48%) | after a round | – | unknown | C | 0% |
| 1 May 2018 | $25.2M | $11.6M – $53.6M | $35.2M (+40%) | after a round | – | unknown | C | 0% |
| 1 Jun 2018 | $26.7M | $11.6M – $53.6M | $35.2M (+32%) | after a round | – | unknown | C | 0% |
| 1 Jul 2018 | $28.3M | $11.6M – $53.6M | $35.2M (+24%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $30.0M | $11.6M – $53.6M | $35.2M (+17%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $31.8M | $11.6M – $53.6M | $35.2M (+11%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $33.7M | $11.6M – $53.6M | $35.2M (+5%) | after a round | – | unknown | C | 0% |
| 1 Nov 2018 | $35.2M | $11.4M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2018 | $35.2M | $10.9M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2019 | $35.2M | $10.3M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2019 | $35.2M | $9.82M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2019 | $35.2M | $9.37M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2019 | $35.2M | $8.91M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2019 | $35.2M | $8.48M – $53.6M | $35.2M (0%) | after a round | – | unknown | C | 0% |
| 23 May 2019 | $156M | $110M – $332M | $234M (+50%) | after a round | – | unknown | B | 0% |
| 1 Jun 2019 | $158M | $110M – $332M | $234M (+48%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $163M | $110M – $332M | $234M (+43%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $169M | $110M – $332M | $234M (+39%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $175M | $110M – $332M | $234M (+34%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $181M | $110M – $332M | $234M (+30%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $187M | $110M – $332M | $234M (+25%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $193M | $110M – $332M | $234M (+21%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $200M | $110M – $332M | $234M (+17%) | after a round | – | unknown | B | 0% |
| 1 Feb 2020 | $207M | $110M – $332M | $234M (+13%) | after a round | – | unknown | B | 0% |
| 1 Mar 2020 | $214M | $110M – $332M | $234M (+9%) | after a round | – | unknown | B | 0% |
| 1 Apr 2020 | $221M | $110M – $332M | $234M (+6%) | after a round | – | unknown | B | 0% |
| 1 May 2020 | $229M | $110M – $332M | $234M (+2%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $234M | $108M – $332M | $234M (0%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $234M | $104M – $332M | $234M (0%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $234M | $99.2M – $332M | $234M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2020 | $234M | $94.9M – $332M | $234M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $234M | $91.0M – $332M | $234M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $234M | $87.0M – $332M | $234M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $234M | $83.4M – $332M | $234M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $234M | $79.8M – $332M | $234M (0%) | after a round | 69 | unknown | C | 0% |
| 1 Feb 2021 | $234M | $76.3M – $332M | $234M (0%) | after a round | 69 | unknown | C | 0% |
| 1 Mar 2021 | $234M | $73.3M – $332M | $234M (0%) | after a round | 69 | unknown | C | 0% |
| 1 Apr 2021 | $234M | $70.2M – $332M | $234M (0%) | after a round | 69 | flat | C | 0% |
| 1 May 2021 | $234M | $67.2M – $332M | $234M (0%) | after a round | 69 | flat | C | 0% |
| 1 Jun 2021 | $234M | $59.3M – $332M | $233M (0%) | after a round | 69 | flat | C | 0% |
| 1 Jul 2021 | $234M | $56.4M – $332M | $231M (-1%) | after a round | 69 | flat | C | 0% |
| 1 Aug 2021 | $234M | $53.6M – $332M | $229M (-2%) | after a round | 69 | flat | C | 0% |
| 1 Sep 2021 | $234M | $51.0M – $332M | $227M (-3%) | after a round | 69 | flat | C | 0% |
| 10 Sep 2021 | $2.4B | $1.7B – $4.3B | $3.1B (+30%) | after a round | 69 | flat | B | 0% |
| 1 Oct 2021 | $2.4B | $1.7B – $4.3B | $3.1B (+28%) | after a round | 69 | flat | B | 0% |
| 1 Nov 2021 | $2.4B | $1.7B – $4.3B | $3.1B (+25%) | after a round | 69 | flat | B | 0% |
| 1 Dec 2021 | $2.5B | $1.7B – $4.3B | $3.1B (+22%) | after a round | 69 | flat | B | 0% |
| 1 Jan 2022 | $2.5B | $1.7B – $4.3B | $3.1B (+20%) | after a round | 110 | growing | B | 0% |
| 1 Feb 2022 | $2.6B | $1.7B – $4.3B | $3.1B (+17%) | after a round | 110 | growing | B | 0% |
| 1 Mar 2022 | $2.7B | $1.7B – $4.3B | $3.1B (+15%) | after a round | 110 | growing | B | 0% |
| 1 Apr 2022 | $2.7B | $1.7B – $4.3B | $3.1B (+12%) | after a round | 110 | growing | B | 0% |
| 1 May 2022 | $2.8B | $1.7B – $4.3B | $3.1B (+10%) | after a round | 110 | growing | B | 0% |
| 1 Jun 2022 | $2.8B | $1.7B – $4.3B | $3.1B (+7%) | after a round | 110 | growing | B | 0% |
| 1 Jul 2022 | $2.9B | $1.7B – $4.3B | $3.1B (+5%) | after a round | 110 | growing | B | 0% |
| 1 Aug 2022 | $3.0B | $1.7B – $4.3B | $3.1B (+3%) | after a round | 110 | growing | B | 0% |
| 1 Sep 2022 | $3.0B | $1.7B – $4.3B | $3.1B (+1%) | after a round | 110 | growing | B | 0% |
| 1 Oct 2022 | $3.1B | $1.7B – $4.3B | $3.1B (0%) | after a round | 110 | growing | B | 0% |
| 1 Nov 2022 | $3.1B | $1.5B – $4.3B | $3.1B (0%) | after a round | 110 | unknown | B | 0% |
| 3 Nov 2022 | $2.0B | $1.7B – $3.0B | $2.6B (+30%) | after a round | 110 | unknown | A | 0% |
| 1 Dec 2022 | $2.0B | $1.7B – $3.0B | $2.6B (+27%) | after a round | 110 | unknown | A | 0% |
| 1 Jan 2023 | $2.1B | $1.7B – $3.0B | $2.6B (+25%) | after a round | 180 | growing | A | 0% |
| 1 Feb 2023 | $2.1B | $1.7B – $3.0B | $2.6B (+22%) | after a round | 180 | growing | A | 0% |
| 1 Mar 2023 | $2.2B | $1.7B – $3.0B | $2.6B (+19%) | after a round | 180 | growing | A | 0% |
| 1 Apr 2023 | $2.2B | $1.7B – $3.0B | $2.6B (+17%) | after a round | 180 | growing | A | 0% |
| 1 May 2023 | $2.3B | $1.7B – $3.0B | $2.6B (+14%) | after a round | 180 | growing | A | 0% |
| 1 Jun 2023 | $2.3B | $1.7B – $3.0B | $2.6B (+12%) | after a round | 180 | growing | A | 0% |
| 1 Jul 2023 | $2.4B | $1.7B – $3.0B | $2.6B (+9%) | after a round | 180 | growing | A | 0% |
| 1 Aug 2023 | $2.4B | $1.7B – $3.0B | $2.6B (+7%) | after a round | 180 | unknown | A | 0% |
| 1 Sep 2023 | $2.5B | $1.7B – $3.0B | $2.6B (+5%) | after a round | 180 | unknown | A | 0% |
| 1 Oct 2023 | $2.6B | $1.7B – $3.0B | $2.6B (+2%) | after a round | 190 | flat | A | 0% |
| 1 Nov 2023 | $2.6B | $1.7B – $3.0B | $2.6B (0%) | after a round | 190 | flat | A | 0% |
| 1 Dec 2023 | $2.6B | $1.7B – $3.0B | $2.6B (0%) | after a round | 190 | flat | A | 0% |
| 1 Jan 2024 | $2.6B | $1.6B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Feb 2024 | $2.6B | $1.5B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Mar 2024 | $2.6B | $1.5B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Apr 2024 | $2.6B | $1.4B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 May 2024 | $2.6B | $1.3B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Jun 2024 | $2.6B | $1.3B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Jul 2024 | $2.6B | $1.2B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Aug 2024 | $2.6B | $1.2B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Sep 2024 | $2.6B | $1.1B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Oct 2024 | $2.6B | $1.1B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Nov 2024 | $2.6B | $1.0B – $3.0B | $2.6B (0%) | after a round | 190 | flat | B | 0% |
| 1 Dec 2024 | $2.6B | $920M – $3.0B | $2.6B (-1%) | after a round | 190 | flat | B | 0% |
| 1 Jan 2025 | $2.6B | $874M – $3.0B | $2.6B (-2%) | after a round | 190 | flat | C | 0% |
| 1 Feb 2025 | $2.6B | $831M – $3.0B | $2.6B (-2%) | after a round | 190 | flat | C | 0% |
| 1 Mar 2025 | $2.6B | $794M – $3.0B | $2.5B (-3%) | after a round | 190 | flat | C | 0% |
| 1 Apr 2025 | $2.6B | $754M – $3.0B | $2.5B (-4%) | after a round | 190 | flat | C | 0% |
| 1 May 2025 | $2.6B | $718M – $3.0B | $2.6B (0%) | after a round | 190 | unknown | C | 0% |
| 1 Jun 2025 | $2.6B | $682M – $3.0B | $2.6B (0%) | after a round | 190 | unknown | C | 0% |
| 1 Jul 2025 | $2.6B | $649M – $3.0B | $2.6B (0%) | after a round | 190 | unknown | C | 0% |
| 1 Aug 2025 | $880M | $577M – $1.9B | $510M (-42%) | after a round | 140 | shrinking | C | 97% |
| 1 Sep 2025 | $848M | $548M – $1.9B | $489M (-42%) | after a round | 140 | shrinking | C | 97% |
| 1 Oct 2025 | $1.2B | $521M – $2.8B | $742M (-36%) | after a round | 139 | flat | C | 89% |
| 1 Nov 2025 | $1.2B | $494M – $2.8B | $785M (-35%) | after a round | 137 | flat | C | 82% |
| 1 Dec 2025 | $1.1B | $470M – $2.8B | $782M (-32%) | after a round | 137 | flat | C | 76% |
| 1 Jan 2026 | $1.2B | $447M – $2.8B | $828M (-30%) | after a round | 138 | flat | C | 70% |
| 1 Feb 2026 | $1.2B | $425M – $2.8B | $872M (-29%) | after a round | 138 | flat | C | 64% |
| 1 Mar 2026 | $1.3B | $406M – $2.8B | $917M (-28%) | after a round | 138 | flat | C | 59% |
| 18 Mar 2026 | $556M | $365M – $921M | $605M (+9%) | after a round | 138 | flat | B | 10% |
| 1 Apr 2026 | $558M | $365M – $921M | $604M (+8%) | after a round | 138 | flat | B | 10% |
| 1 May 2026 | $560M | $365M – $899M | $581M (+4%) | after a round | 130 | flat | B | 36% |
| 1 Jun 2026 | $563M | $365M – $899M | $575M (+2%) | after a round | 130 | flat | B | 36% |
| 1 Jul 2026 | $566M | $365M – $899M | $569M (+1%) | after a round | 130 | flat | B | 36% |
| 1 Aug 2026 | $573M | $369M – $912M | $573M (0%) | after a round | 137 | flat | B | 33% |
| 1 Sep 2026 | $577M | $369M – $914M | $572M (-1%) | after a round | 137 | flat | B | 30% |
| 1 Oct 2026 | $581M | $369M – $915M | $570M (-2%) | after a round | 136 | flat | B | 28% |
| 24 Oct 2026 | $584M | $369M – $917M | $570M (-2%) | after a round | 136 | flat | B | 26% |
Key facts about Solugen
- Founded
- 2016
- Headquarters
- Houston, United States
- Employees
- about 136 -2% in a year
- Total raised
- $850M
- Funding rounds
- 6
- Last round
- Growth Equity Mar 2026
Solugen was founded in 2016 by Gaurab Chakrabarti and Sean Hunt.
Solugen funding history
Solugen has 6 funding rounds on record, from Oct 2017 to Mar 2026, $850M in total. The latest disclosed valuation is $2.00B post-money (Series D, Nov 2022).
$50M
$214M
Series D 2 Nov 2022
Led by Kinnevik, Lowercarbon Capital, Refactor Capital; with Temasek, Baillie Gifford, Fifty Years.
Sources: solugen.com, prnewswire.com, carbonherald.com and 2 more
$200M
$2.00B post-money
Series C 9 Sep 2021
Led by GIC, Baillie Gifford; with Temasek, BlackRock, Carbon Direct Capital, Refactor Capital, Fifty Years.
Sources: solugen.com, axios.com, prnewswire.com and 5 more
$350M
Series B 22 May 2019
Led by Founders Fund; with Y Combinator, Refactor Capital, Fifty Years, KdT Ventures.
Sources: solugen.com, synbiobeta.com, houston.innovationmap.com and 2 more
$32M
Seed 24 Oct 2017
Led by Social Capital; with Y Combinator, Refactor Capital, Liquid 2, Massachusetts Institute of Technology, MIT.
Sources: agfundernews.com, trellis.net
$4.4M
Solugen investors
19 investors have backed Solugen; Refactor Capital, Baillie Gifford and Founders Fund and 6 more led at least one round.
- Baillie Gifford lead, 2 rounds
- Founders Fund lead
- GIC lead
- Kinnevik lead
- Lowercarbon Capital lead
- Social Capital lead
- U.S. Department of Energy lead
- Temasek 2 rounds
- Y Combinator 2 rounds
- BlackRock
- Canada Growth Fund
- Massachusetts Institute of Technology
- MIT
What Solugen does
Solugen works in chemicals, with 16 recorded offerings and customers in oil & gas, renewable fuels, aerospace & defense and water treatment.
Solugen, Inc. is an American chemical manufacturing company engaged in the development and production of sustainable chemical solutions. The company operates biomanufacturing facilities and a distribution warehouse, and its activities include the manufacture of bio-based building block molecules, engineered enzymes, and metal catalysts for industries such as oil and gas, renewable fuels, aerospace and defense, water treatment, cleaning, agriculture, concrete, and personal care. Solugen also develops modular manufacturing systems that utilize engineered enzymes, plant-based feedstocks, and catalytic reactions to produce emission-free materials. The company is certified and has received industry recognition for its sustainability initiatives.
Description from Veridion's company data.
Products and services
- Sustainable Chemical Manufacturing
- Biomanufacturing Facility Operation
- Engineered Enzyme Development
- Metal Catalyst Development
- Bio-Based Building Block Production
- Modular Manufacturing Platform Deployment
- Carbon Negative Molecule Manufacturing
- Industrial Chemical Solutions Development
- Renewable Chemical Solutions Development
- Agricultural Chemical Solutions Development
- Water Treatment Chemical Solutions Development
- Cleaning Chemical Solutions Development
- Concrete Chemical Solutions Development
- Personal Care Chemical Solutions Development
- Global Bioforge Network Expansion
- Sustainable Feedstock Utilization Services
Markets
- Oil & Gas
- Renewable Fuels
- Aerospace & Defense
- Water Treatment
- Cleaning
- Agriculture
- Concrete
- Personal Care
Technology
- Engineered Enzymes
- Metal Catalysts
- Modular Manufacturing System
- Sustainable Feedstocks
Supply chain
- Sustainable Sourcing
- Regional Distribution Centers
Business model
- Business-to-Business
- Manufacturing
Industry codes (NAICS)
- 325199 All Other Basic Organic Chemical Manufacturing 75% match
- 424690 Other Chemical and Allied Products Merchant Wholesalers 25% match
Questions about Solugen
What is Solugen worth?
Valuation $584M (range $369M to $917M), as of 24 Oct 2026. The last disclosed valuation was $2.00B (Series D, Nov 2022).
Has Solugen raised money?
Solugen has 6 funding rounds on record, from Oct 2017 to Mar 2026, $850M in total. The latest disclosed valuation is $2.00B post-money (Series D, Nov 2022).
Who has invested in Solugen?
Refactor Capital, Baillie Gifford, Founders Fund, GIC, Idealist Capital and Kinnevik, and 13 more. Lead investors include Refactor Capital, Baillie Gifford, Founders Fund and GIC.
How many people work at Solugen?
About 136, down 2% over the last year. Headcount rose from 69 in Jan 2021 to 190 in Oct 2023, then fell to 136 in Sep 2026.
What does Solugen do?
Solugen works in chemicals, with 16 recorded offerings and customers in oil & gas, renewable fuels, aerospace & defense and water treatment. Its main offerings are sustainable chemical manufacturing, biomanufacturing facility operation and engineered enzyme development.
When was Solugen founded, and where is it based?
Solugen was founded in 2016 and is based in Houston, United States. It has about 136 employees, down 2% over the last year.